Dr. Wouter Schievink, MD

Dr. Schievink practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Schievink's NPI, 1275517195, was assigned on December 5, 2005. Dr. Schievink graduated from University of Amsterdam Faculty of Medicine in 1989. Dr. Schievink's California license number on file is A65208.

Dr. Schievink's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Schievink's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schievink practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Schievink's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Schievink is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Schievink's licenses on file in 3 states: California, Arizona and Minnesota.

Dmand AI lists craniotomy, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Schievink treats.

CMS data shows 249 Medicare services from Dr. Schievink across 5 procedure codes in 2024, for 189 Medicare patients. Medicare paid $63,113 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Schievink in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high cholesterol, and 72% have arthritis. 19% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schievink's median patient age at 60, with 65% women.

In 2017, Dr. Schievink wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $35 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schievink for performance year 2024, reported as part of a group. Dr. Schievink accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Schievink, published from 2004 to 2025. 2025 was the busiest year, with 5. Dr. Schievink has published most often in AJNR Am J Neuroradiol. Dr. Schievink's most frequent co-authors are Julie Lynn Chan, MD, PhD, Ajay Akash Madhavan, MD and Marcel M. Maya, MD.

CMS Open Payments shows 12 general payments to Dr. Schievink from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 75% of the total. Surgical Theater LLC paid the most, $604.

Dmand AI lists 4 awards for Dr. Schievink, most recently Top Doctors:LA Area in 2013.

Dr. Schievink graduated from University of Amsterdam Faculty of Medicine in 1989. Dr. Schievink is a member of AANS.

Dr. Schievink is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.